Advertisement

Topics

Capricor Therapeutics, Inc. Company Profile

08:38 EST 15th December 2018 | BioPortfolio

Capricor Therapeutics, Inc. (CAPR), a publicly traded biotechnology company, is focused on the development of novel therapeutics to prevent and treat heart disease. The Company was formed through the November 2013 merger between Capricor, Inc., a privately held company whose mission is to improve the treatment of heart disease by commercializing cardiac stem cell therapies for patients, and Nile Therapeutics, Inc., a clinical-stage biopharmaceutical company developing innovative products for the treatment of cardiovascular diseases. For additional information visit www.capricor.com.


News Articles [709 Associated News Articles listed on BioPortfolio]

Capricor Therapeutics working on drug to treat a rare disorder DMD

Capricor Therapeutics (NASDAQ:CAPR) CFO AJ Bergmann joined Steve Darling and Proactive investors in California to talk about their drug for treating a rare childhood disease called Duchenne muscular...

Global Exosome Technologies Market to 2024: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players” report has been added to ResearchAndMa...

Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2018 Results - Earnings Call Transcript

Capricor Therapeutics Inc CAPR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCapricor Therapeutics Inc Capricor is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac...

Capricor Therapeutics Inc CAPR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryCapricor Therapeutics Inc Capricor is a clinicalstage biotechnology company that discovers, develops and commercializes therapeutics for cardiac and various diseases. It offers cardiac cell the...

Exosome Technologies: Recent Surge in RD with Capricor, Codiak and Evox Therapeutics among Key Players [Report Updated: 12102018] Prices from USD $2995

Exosome Technologies: Recent Surge in RD with Capricor, Codiak and Evox Therapeutics among Key PlayersSummaryGBI Research's latest report, Exosome Technologies: Recent Surge in RD with Capricor, Codia...

Global Cell Therapy Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Bone Marrow Transplant Rejection Treatment Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development.

Clinical Trials [164 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1286 Associated Companies listed on BioPortfolio]

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. (CAPR), a publicly traded biotechnology company, is focused on the development of novel therapeutics to prevent and treat heart disease. The Company wa...

Capricor, Inc.

Los Angeles-based Capricor is a biotechnology company that aims to create powerful, yet easy-to-administer cardiac stem cell treatments to regenerate the heart and improve its fun...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Capricor Therapeutics, Inc." on BioPortfolio

We have published hundreds of Capricor Therapeutics, Inc. news stories on BioPortfolio along with dozens of Capricor Therapeutics, Inc. Clinical Trials and PubMed Articles about Capricor Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Capricor Therapeutics, Inc. Companies in our database. You can also find out about relevant Capricor Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record